v3.23.1
Collaborations (Tables)
 3 Months Ended
Mar. 31, 2023
Janssen Biotech Inc.  
Collaborative and license agreements  
Schedule of profit and cost sharing relationship The following table shows the profit and cost sharing relationship between Janssen and AbbVie:
Three months ended
March 31,
(in millions)20232022
United States - Janssen's share of profits (included in cost of products sold)$297 $408 
International - AbbVie's share of profits (included in net revenues)240 299 
Global - AbbVie's share of other costs (included in respective line items)55 64 
Genentech, Inc.  
Collaborative and license agreements  
Schedule of profit and cost sharing relationship The following table shows the profit and cost sharing relationship between Genentech and AbbVie:
Three months ended
March 31,
(in millions)20232022
Genentech's share of profits, including royalties (included in cost of products sold)$202 $178 
AbbVie's share of sales and marketing costs from U.S. collaboration (included in SG&A)11 12 
AbbVie's share of development costs (included in R&D)28 27